We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

AstraZeneca plc Could Help You Retire Early

Retirement may not be so long away for shareholders in AstraZeneca plc (LON: AZN). Here’s why…

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

If, like me, you think that the stock market is looking rather high at the moment and could be due a fall, AstraZeneca (LSE: AZN) (NYSE: AZN.US) could be a great company to add to your portfolio.

The reason is that it has a relatively low beta. Indeed, AstraZeneca’s beta is just 0.8, which means that for every 10% fall in the FTSE 100, AstraZeneca should fall 8% (in theory). This would mean that your potential losses from a ‘correction’, ‘bear market or ‘fall’ (or whatever else you’d like to call a setback in the stock market) could be lessened by investing in AstraZeneca.

Should you buy AstraZeneca Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Of course, the reverse is also true. For every 10% rise in the stock market, AstraZeneca should only go up by 8% (in theory). However, this reduced overall volatility may be rewarded over the long run via higher demand for shares, meaning AstraZeneca could demand a more generous long term valuation as a result. This would be positive for your retirement plans.

In addition, the vast majority of AstraZeneca’s products are patent protected. This provides the company with a significant amount of protection with regards to its revenue visibility. In other words, AstraZeneca is more likely to meet revenue guidance because demand for its drugs is likely to remain and, since it is currently the only producer of the drugs, its revenue should be relatively easy to predict over the short to medium term.

In times of panic and fear, such stability and visibility are generally sought by investors, making the likes of AstraZeneca popular in downturns. Should the stock market fall, your portfolio may be boosted by the inclusion of AstraZeneca.

Furthermore, AstraZeneca could help retirement come that little bit sooner because it trades on a relatively high free cash flow yield, which provides evidence that shares are good value at current prices. A free cash flow yield of 8.9% is extremely high for a large-cap stock like AstraZeneca and it would be of no great surprise for this to fall in future years, with the share price potentially moving in the opposite direction.

Of course, an upward movement would be great news for investors in the stock and could mean their retirement days come sooner than expected.

> Peter owns shares in AstraZeneca.

More on Investing Articles

The Ocean Village Marina neighborhood of Southampton on the Channel coast in southern England, UK.
Investing Articles

How much do you need in your SIPP to target a £575 monthly passive income?

Harvey Jones says many investors overlook the attractions of a Self-Invested Personal Pension but it can work nicely alongside an…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Here’s what £3,000 put into Rolls-Royce shares a year ago is worth now…

What has the soaring value of Rolls-Royce shares meant for a few thousands pounds put in just 12 months ago?…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Could £300 a month and UK dividend shares yielding 5% really grow to £176,436?

UK shares pay some of the best dividends in the world. James Beard considers how they could be used to…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Prediction: by 2027, this battered FTSE AIM stock could turn £3,000 into…

The Boohoo share price is down 93% in five years. But does it now deserve a place on investors' radars…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Growth Shares

Up 38% in a year, here’s why some still think Barclays shares are dead cheap

Jon Smith explains why Barclays shares could still be considered attractive even with the run up over the past year,…

Read more »

Picture of an easyJet plane taking off.
Investing Articles

Could easyJet shares be 85% undervalued?

A US investment firm is considering making an offer for easyJet. But how much would it cost to buy all…

Read more »

Rolls-Royce engineer working on an engine
Investing Articles

Rolls-Royce shares have suddenly become boring! What’s going on?

Rolls-Royce Holdings' shares are back where they were at the start of the year. Could this be a golden opportunity…

Read more »

Satellite on planet background
Investing Articles

Should investors consider buying BAE Systems shares now they’re back below £20?

BAE Systems shares are currently trading about 17% below their 2026 highs. Is now the time to consider them for…

Read more »